lancet-header
Preprints with The Lancet is part of SSRN´s First Look, a place where journals and other research experts identify content of interest prior to publication. These preprint papers are not peer-reviewed. Authors have either opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet, or submitted directly via SSRN. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. These papers should not be used for clinical decision making or reporting of research to a lay audience without indicating that this is preliminary research that has not been peer-reviewed. For more information see the Comment published in The Lancet, or visit The Lancet´s FAQ page, and for any feedback please contact preprints@lancet.com

Prevalence of Diabetes Mellitus in 2019 Novel Coronavirus: A Meta-Analysis

23 Pages Posted: 31 Mar 2020

See all articles by Xiang Wang

Xiang Wang

Zhengzhou University - Department of Endocrinology and Metabolism

Shoujun Wang

Zhengzhou University - Department of Endocrinology and Metabolism

Liangge Sun

Zhengzhou University - Department of Endocrinology and Metabolism

Guijun Qin

Zhengzhou University - Division of Endocrinology

More...

Abstract

Background: Since December 2019, a new strain of coronavirus named 2019 novel coronavirus (2019-nCoV) has been discovered in Wuhan. The prevalence of diabetes mellitus, which is a great public health issue leading to immunity inhibition and an increased incidence of infections, has been increasing over the past ten years. The aim of this research was to systematically assess the prevalence of diabetes mellitus among 2019-nCoV.

Methods: We searched PubMed, Embase, Web of Science and Medline for observational studies up to February 25, 2020. A random effects model or fixed-effects model was applied to evaluate the pooled prevalence of diabetes mellitus and odds ratio (OR) with 95% confidence interval (CI).

Findings: In total, nine papers met the eligibility criteria. The pooled prevalence of DM was 9% (95% CI 6%–12%). There was obvious heterogeneity (I 2 65%, p=0.004) in the prevalence of DM in these studies. The prevalence of DM in moderate patients with 2019-nCoV was 7% (95% CI 4%–10%). The prevalence of DM in severe patients with 2019-nCoV was 17% (95% CI 13%–21%). The prevalence of DM in severe patients with 2019-nCoV was significantly higher than that in moderate patients with 2019-nCoV (OR 2.49, 95% CI 1.70 to 3.64).

Interpretation: To our knowledge, this work is the first report showing the prevalence of diabetes mellitus in patients with 2019-nCoV, which is beneficial to prevent the spread of 2019-nCoV in the future.

Funding Statement: Natural Science Foundation of Henan Province of China (Grant number: 162300410306).

Declaration of Interests: None.

Keywords: 2019 novel coronavirus, diabetes mellitus, prevalence, meta-analysis

Suggested Citation

Wang, Xiang and Wang, Shoujun and Sun, Liangge and Qin, Guijun, Prevalence of Diabetes Mellitus in 2019 Novel Coronavirus: A Meta-Analysis (3/13/2020). Available at SSRN: https://ssrn.com/abstract=3556650 or http://dx.doi.org/10.2139/ssrn.3556650

Xiang Wang (Contact Author)

Zhengzhou University - Department of Endocrinology and Metabolism ( email )

China

Shoujun Wang

Zhengzhou University - Department of Endocrinology and Metabolism

China

Liangge Sun

Zhengzhou University - Department of Endocrinology and Metabolism

China

Guijun Qin

Zhengzhou University - Division of Endocrinology ( email )

Click here to go to TheLancet.com

Paper statistics

Abstract Views
578
Downloads
73